Chondroitin sulfate is a natural substance which is found in connective tissues like cartilage. It plays a key role in maintaining the lubrication and flexibility in the joints. Demand for chondroitin sulfate is rising in nutraceuticals and dietary supplements as it helps in improving mobility and reducing joint pains associated with osteoarthritis.
The global Chondroitin Sulfate Market is estimated to be valued at US$ 1288.13 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Chondroitin sulfate supplements help in maintaining flexible and lubricated joints without any side effects. Clinical studies have proven chondroitin sulfate’s efficacy in reducing the symptoms of osteoarthritis and improving mobility. The rising health awareness about managing joint pain through natural ingredients is fueling the demand for chondroitin sulfate supplements. An increasing number of nutraceutical and pharmaceutical manufacturers are incorporating chondroitin sulfate into their joint pain relief products considering its natural properties and clinically proven benefits.
The global chondroitin sulfate market is segmented based on source, application, and region. Based on source, pharmaceutical grade chondroitin sulfate dominates the market. It is widely used in nutraceuticals and pharmaceuticals owing to its purity and standardization. Pharmaceutical grade chondroitin sulfate ensures consistency in composition and quality, providing desired therapeutic effects.
The Global Chondroitin Sulfate Market Size is expected to witness high growth, exhibiting CAGR of 3.1% over the forecast period, due to increasing demand from nutraceuticals and pharmaceuticals industries.
North America is expected to dominate the global chondroitin sulfate market over the forecast period. Favorable government regulations regarding the usage of chondroitin sulfate supplements in the region and increasing health awareness among consumers drive the market growth.
Key players operating in the chondroitin sulfate market are TSI Group Ltd., Qingdao Wan Toulmin Biological Products Co., Ltd, HeBei SanXin Industrial Group, Bioiberica S.A.U., Sigma-Aldrich, Inc., Sino Siam Biotechnique Company Limited, Bio-gen Extracts Private Limited, SEIKAGAKU CORPORATION, BRF, and ZPD. Pharmaceutical grade products with consistent quality are key strategies adopted by these players to lead the market.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it